Acelyrin (SLRN) Reports Positive Phase 3 Data for Izokibep in Hidradenitis Suppurativa

Go back to Acelyrin (SLRN) Reports Positive Phase 3 Data for Izokibep in Hidradenitis Suppurativa
Solar 18 Corporation (NASDAQ: SLRN) Delayed: 2.27 --0 (-0%)
Previous Close $2.27    52 Week High $0.01 
Open $2.27    52 Week Low $0.00 
Day High $2.27    P/E N/A 
Day Low $2.27    EPS $0.00 
Volume